{"id":73,"date":"2025-11-13T10:12:46","date_gmt":"2025-11-13T18:12:46","guid":{"rendered":"https:\/\/insidemultisite.salk.edu\/spring-2026\/?p=73"},"modified":"2026-08-09T15:25:01","modified_gmt":"2026-08-09T22:25:01","slug":"from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial","status":"publish","type":"post","link":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/","title":{"rendered":"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial"},"content":{"rendered":"\n<details class=\"wp-block-details is-layout-flow wp-block-details-is-layout-flow\"><summary><em>NATURE CANCER&nbsp;<\/em><br><em>05\/2026&nbsp;<\/em><\/summary>\n<p><\/p>\n<\/details>\n\n\n\n<p>A small clinical trial led by the Dana-Farber Cancer Institute put a Salk Institute idea to the test in patients: that activating the vitamin D receptor can help reshape the protective environment surrounding pancreatic tumors in ways that could make the notoriously difficult-to-treat cancer more vulnerable to therapeutic treatments.<\/p>\n\n\n\n<p>In the study co-authored by <a href=\"https:\/\/www.salk.edu\/scientist\/ronald-evans\/\" target=\"_blank\" rel=\"noreferrer noopener\">Ronald Evans, PhD<\/a>, patients with previously untreated metastatic pancreatic cancer received standard chemotherapy with or without paricalcitol\u2014a vitamin D analog that is already FDA-approved for other uses. In patients who received paricalcitol orally or intravenously, the combination was found to be safe and to reduce activation of fibroblasts in the tumor microenvironment, validating Salk\u2019s preclinical findings. The trial was not intended to measure how well the approach works in treating pancreatic cancer, yet the researchers noted improved chemotherapy responses and increased progression-free survival at one year among patients who received paricalcitol plus chemotherapy. In addition, they found that patients with high vitamin D receptor expression and who received paricalcitol had the longest overall survival rate.<\/p>\n\n\n\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\">\n<p><em>\u201cThis study really takes a novel approach for cracking therapeutic resistance in pancreatic cancer. By using vitamin D analogs to engage the body\u2019s own natural system for dampening fibrotic and inflammatory responses, we can enable other therapies to do their job.\u201d<\/em><\/p>\n\n\n\n<p>Ronald Evans<\/p>\n<\/blockquote>\n\n\n\n<p><a href=\"https:\/\/www.salk.edu\/news-release\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/\" target=\"_blank\" rel=\"noreferrer noopener\">Read news release<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A small clinical trial led by the Dana-Farber Cancer Institute put a Salk Institute idea to the test in patients: that activating the vitamin D receptor can help reshape the protective environment surrounding pancreatic tumors in ways that could make the notoriously difficult-to-treat cancer more vulnerable to therapeutic treatments. In the study co-authored by Ronald [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":1155,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27,8,24],"tags":[],"class_list":["post-73","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cancer","category-discoveries","category-discoveries-home"],"blocksy_meta":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial - Inside Salk | Fall 2026<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial - Inside Salk | Fall 2026\" \/>\n<meta property=\"og:description\" content=\"A small clinical trial led by the Dana-Farber Cancer Institute put a Salk Institute idea to the test in patients: that activating the vitamin D receptor can help reshape the protective environment surrounding pancreatic tumors in ways that could make the notoriously difficult-to-treat cancer more vulnerable to therapeutic treatments. In the study co-authored by Ronald [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"Inside Salk | Fall 2026\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/salkinstitute\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-13T18:12:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-09T22:25:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/inside.salk.edu\/fall-2026\/wp-content\/uploads\/sites\/6\/2025\/11\/2026-inside-salk-fall-discoveries-cancer.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"450\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Salk Institute\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@salkinstitute\" \/>\n<meta name=\"twitter:site\" content=\"@salkinstitute\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Salk Institute\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/\"},\"author\":{\"name\":\"Salk Institute\",\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/#\\\/schema\\\/person\\\/db0e26e1bda71d70b6d1bd4a1a3de862\"},\"headline\":\"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial\",\"datePublished\":\"2025-11-13T18:12:46+00:00\",\"dateModified\":\"2026-08-09T22:25:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/\"},\"wordCount\":241,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2025\\\/11\\\/2026-inside-salk-fall-discoveries-cancer.jpg\",\"articleSection\":[\"Cancer\",\"Discoveries\",\"Discoveries Home\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/\",\"url\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/\",\"name\":\"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial - Inside Salk | Fall 2026\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2025\\\/11\\\/2026-inside-salk-fall-discoveries-cancer.jpg\",\"datePublished\":\"2025-11-13T18:12:46+00:00\",\"dateModified\":\"2026-08-09T22:25:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/#primaryimage\",\"url\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2025\\\/11\\\/2026-inside-salk-fall-discoveries-cancer.jpg\",\"contentUrl\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2025\\\/11\\\/2026-inside-salk-fall-discoveries-cancer.jpg\",\"width\":900,\"height\":450,\"caption\":\"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/#website\",\"url\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/\",\"name\":\"Inside Salk | Fall 2025\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/#organization\",\"name\":\"Salk Institute\",\"url\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2025\\\/11\\\/salk_placeholder.jpg\",\"contentUrl\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/wp-content\\\/uploads\\\/sites\\\/6\\\/2025\\\/11\\\/salk_placeholder.jpg\",\"width\":256,\"height\":256,\"caption\":\"Salk Institute\"},\"image\":{\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/salkinstitute\",\"https:\\\/\\\/x.com\\\/salkinstitute\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/salk-institute-for-biological-studies\",\"https:\\\/\\\/www.youtube.com\\\/salkinstitute\",\"https:\\\/\\\/www.instagram.com\\\/salkinstitute\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/#\\\/schema\\\/person\\\/db0e26e1bda71d70b6d1bd4a1a3de862\",\"name\":\"Salk Institute\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1ed63f44f07a2f350e49971c2d12607877b9edf7508df76137b71b0c5140e3f?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1ed63f44f07a2f350e49971c2d12607877b9edf7508df76137b71b0c5140e3f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f1ed63f44f07a2f350e49971c2d12607877b9edf7508df76137b71b0c5140e3f?s=96&d=mm&r=g\",\"caption\":\"Salk Institute\"},\"url\":\"https:\\\/\\\/inside.salk.edu\\\/fall-2026\\\/author\\\/salk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial - Inside Salk | Fall 2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/","og_locale":"en_US","og_type":"article","og_title":"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial - Inside Salk | Fall 2026","og_description":"A small clinical trial led by the Dana-Farber Cancer Institute put a Salk Institute idea to the test in patients: that activating the vitamin D receptor can help reshape the protective environment surrounding pancreatic tumors in ways that could make the notoriously difficult-to-treat cancer more vulnerable to therapeutic treatments. In the study co-authored by Ronald [&hellip;]","og_url":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/","og_site_name":"Inside Salk | Fall 2026","article_publisher":"https:\/\/www.facebook.com\/salkinstitute","article_published_time":"2025-11-13T18:12:46+00:00","article_modified_time":"2026-08-09T22:25:01+00:00","og_image":[{"width":900,"height":450,"url":"https:\/\/inside.salk.edu\/fall-2026\/wp-content\/uploads\/sites\/6\/2025\/11\/2026-inside-salk-fall-discoveries-cancer.jpg","type":"image\/jpeg"}],"author":"Salk Institute","twitter_card":"summary_large_image","twitter_creator":"@salkinstitute","twitter_site":"@salkinstitute","twitter_misc":{"Written by":"Salk Institute","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/#article","isPartOf":{"@id":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/"},"author":{"name":"Salk Institute","@id":"https:\/\/inside.salk.edu\/fall-2026\/#\/schema\/person\/db0e26e1bda71d70b6d1bd4a1a3de862"},"headline":"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial","datePublished":"2025-11-13T18:12:46+00:00","dateModified":"2026-08-09T22:25:01+00:00","mainEntityOfPage":{"@id":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/"},"wordCount":241,"commentCount":0,"publisher":{"@id":"https:\/\/inside.salk.edu\/fall-2026\/#organization"},"image":{"@id":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/inside.salk.edu\/fall-2026\/wp-content\/uploads\/sites\/6\/2025\/11\/2026-inside-salk-fall-discoveries-cancer.jpg","articleSection":["Cancer","Discoveries","Discoveries Home"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/","url":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/","name":"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial - Inside Salk | Fall 2026","isPartOf":{"@id":"https:\/\/inside.salk.edu\/fall-2026\/#website"},"primaryImageOfPage":{"@id":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/#primaryimage"},"image":{"@id":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/#primaryimage"},"thumbnailUrl":"https:\/\/inside.salk.edu\/fall-2026\/wp-content\/uploads\/sites\/6\/2025\/11\/2026-inside-salk-fall-discoveries-cancer.jpg","datePublished":"2025-11-13T18:12:46+00:00","dateModified":"2026-08-09T22:25:01+00:00","breadcrumb":{"@id":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/#primaryimage","url":"https:\/\/inside.salk.edu\/fall-2026\/wp-content\/uploads\/sites\/6\/2025\/11\/2026-inside-salk-fall-discoveries-cancer.jpg","contentUrl":"https:\/\/inside.salk.edu\/fall-2026\/wp-content\/uploads\/sites\/6\/2025\/11\/2026-inside-salk-fall-discoveries-cancer.jpg","width":900,"height":450,"caption":"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial"},{"@type":"BreadcrumbList","@id":"https:\/\/inside.salk.edu\/fall-2026\/from-salk-institute-discovery-to-patient-care-vitamin-d-analog-shuts-down-pancreatic-cancers-shield-in-clinical-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/inside.salk.edu\/fall-2026\/"},{"@type":"ListItem","position":2,"name":"From Salk Institute discovery to patient care: Vitamin D analog shuts down pancreatic cancer\u2019s shield in clinical trial"}]},{"@type":"WebSite","@id":"https:\/\/inside.salk.edu\/fall-2026\/#website","url":"https:\/\/inside.salk.edu\/fall-2026\/","name":"Inside Salk | Fall 2025","description":"","publisher":{"@id":"https:\/\/inside.salk.edu\/fall-2026\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/inside.salk.edu\/fall-2026\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/inside.salk.edu\/fall-2026\/#organization","name":"Salk Institute","url":"https:\/\/inside.salk.edu\/fall-2026\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/inside.salk.edu\/fall-2026\/#\/schema\/logo\/image\/","url":"https:\/\/inside.salk.edu\/fall-2026\/wp-content\/uploads\/sites\/6\/2025\/11\/salk_placeholder.jpg","contentUrl":"https:\/\/inside.salk.edu\/fall-2026\/wp-content\/uploads\/sites\/6\/2025\/11\/salk_placeholder.jpg","width":256,"height":256,"caption":"Salk Institute"},"image":{"@id":"https:\/\/inside.salk.edu\/fall-2026\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/salkinstitute","https:\/\/x.com\/salkinstitute","https:\/\/www.linkedin.com\/company\/salk-institute-for-biological-studies","https:\/\/www.youtube.com\/salkinstitute","https:\/\/www.instagram.com\/salkinstitute\/"]},{"@type":"Person","@id":"https:\/\/inside.salk.edu\/fall-2026\/#\/schema\/person\/db0e26e1bda71d70b6d1bd4a1a3de862","name":"Salk Institute","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f1ed63f44f07a2f350e49971c2d12607877b9edf7508df76137b71b0c5140e3f?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f1ed63f44f07a2f350e49971c2d12607877b9edf7508df76137b71b0c5140e3f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f1ed63f44f07a2f350e49971c2d12607877b9edf7508df76137b71b0c5140e3f?s=96&d=mm&r=g","caption":"Salk Institute"},"url":"https:\/\/inside.salk.edu\/fall-2026\/author\/salk\/"}]}},"_links":{"self":[{"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/posts\/73","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/comments?post=73"}],"version-history":[{"count":10,"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/posts\/73\/revisions"}],"predecessor-version":[{"id":1215,"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/posts\/73\/revisions\/1215"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/media\/1155"}],"wp:attachment":[{"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/media?parent=73"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/categories?post=73"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inside.salk.edu\/fall-2026\/wp-json\/wp\/v2\/tags?post=73"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}